Table of Contents
- What is Lactobacillus Acidophilus La14?
- What is Lactobacillus Acidophilus Rossel 52?
- What is Lactobacillus Acidophilus NCFM® 8?
- What Lactobacillus Acidophilus La5?
- Want to know more?
What is Lactobacillus Acidophilus La14?
Lactobacillus Acidophilus La14 is a lactic acid bacterium that supports the vaginal microbiome. It acts like a probiotic, so it can also be used to prevent diarrhea.
Research shows that Lactobacillus Accidophlis La14, when taken orally, may assist in increasing the good bacteria present in the vagina, aiding in the balance of bacteria present and supporting vaginal health for the better. Having more good bacteria present in the vaginal microbiome may help eliminate pathogens that may cause bacterial vaginosis (BV), a common STD.
However, more research is required to confirm these effects of Lactobacillus Accidophlis La14 on the vaginal microbiome.
In the video below, Dr. Eric Berg shares the benefits of Lactobacillus bacteria:
This is our recommended Probiotic Supplement with Lactobacillus Acidophilus:
What is Lactobacillus Acidophilus Rosell 52?
The Lactobacillus Acidophilus Rossel 52 strain is a probiotic bacteria mainly used to support the gastrointestinal system because of its anti-pathogenic behavior. Although, it has also been used in immunity and mental health.
Studies have found Lactobacillus Acidophilus Rossel 52 to help treat the following:
While more research is required to confirm the effects of using Lactobacillus Acidophilus Rossel 52 to manage the following:
What is Lactobacillus Acidophilus NCFM® 8?
Lactobacillus Acidophilus NCFM® 8 is a probiotic bacteria mostly used to support general health and the gastrointestinal system because of its anti-pathogenic behavior. Lactobacillus Acidophilus NCFM® 8 is one of the most researched probiotics with over 45 clinical trials. These trials have identified its potential benefits in increasing immunity and preventing antibiotic-associated gut disorders.
Clinical trials have found Lactobacillus Acidophilus NCFM® 8 to help treat the following:
Although more research is required to confirm this effect, Lactobacillus Acidophilus NCFM® 8 has also boosted immunity.
What is Lactobacillus Acidophilus La5?
Lactobacillus Acidophilus La5 strain is a probiotic food supplement that can make the internal environment of the intestine less inhabitable to harmful pathogens. Lactobacillus Acidophilus La5 produces metabolites (lactic acid, acetic acid, and hydrogen peroxide) in the body.
Studies have found Lactobacillus Acidophilus la5 to help treat the following:
While more research is required to confirm the effects of using Lactobacillus Acidophilus La5 to manage the following
Want to know more?
Click the links below to access the individual topic pages:
This article makes use of information from the U.S. National Library of Medicine under the terms of the Creative Commons Attribution 4.0 International License.
- Bertuccini L, Russo R, Iosi F, Superti F. Effects of Lactobacillus rhamnosus and Lactobacillus acidophilus on bacterial vaginal pathogens. Int J Immunopathol Pharmacol. 2017 Jun;30(2):163-167. doi: 10.1177/0394632017697987. Epub 2017 Mar 1. PMID: 28580872; PMCID: PMC5806794.
- Preston K, Krumian R, Hattner J, de Montigny D, Stewart M, Gaddam S. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study. Benef Microbes. 2018 Sep 18;9(5):697-706. doi: 10.3920/BM2017.0105. Epub 2018 Jun 11. PMID: 29888656.
- Korpela R, Niittynen L. Probiotics and irritable bowel syndrome. Microb Ecol Health Dis. 2012 Jun 18;23. doi: 10.3402/mehd.v23i0.18573. PMID: 23990830; PMCID: PMC3747754.
- Cazzola M, Pham-Thi N, Kerihuel JC, Durand H, Bohbot S. Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study. Ther Adv Respir Dis. 2010 Oct;4(5):271-8. doi: 10.1177/1753465810379010. Epub 2010 Aug 20. PMID: 20729255.
- Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, Bisson JF, Rougeot C, Pichelin M, Cazaubiel M, Cazaubiel JM. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011 Mar;105(5):755-64. doi: 10.1017/S0007114510004319. Epub 2010 Oct 26. PMID: 20974015.
- Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. World J Gastroenterol. 2016 Dec 28;22(48):10631-10642. doi: 10.3748/wjg.v22.i48.10631. PMID: 28082816; PMCID: PMC5192275.
- Heiser CR, Ernst JA, Barrett JT, French N, Schutz M, Dube MP. Probiotics, soluble fiber, and L-Glutamine (GLN) reduce nelfinavir (NFV)- or lopinavir/ritonavir (LPV/r)-related diarrhea. J Int Assoc Physicians AIDS Care (Chic). 2004 Oct-Dec;3(4):121-9. doi: 10.1177/154510970400300403. PMID: 15768732.
- Magro DO, de Oliveira LM, Bernasconi I, Ruela Mde S, Credidio L, Barcelos IK, Leal RF, Ayrizono Mde L, Fagundes JJ, Teixeira Lde B, Ouwehand AC, Coy CS. Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation. Nutr J. 2014 Jul 24;13:75. doi: 10.1186/1475-2891-13-75. PMID: 25056655; PMCID: PMC4113128.
- Paineau D, Carcano D, Leyer G, Darquy S, Alyanakian MA, Simoneau G, Bergmann JF, Brassart D, Bornet F, Ouwehand AC. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol. 2008 Jun;53(1):107-13. doi: 10.1111/j.1574-695X.2008.00413.x. Epub 2008 Apr 15. PMID: 18422632.
- Sheu BS, Wu JJ, Lo CY, Wu HW, Chen JH, Lin YS, Lin MD. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2002 Sep;16(9):1669-75. doi: 10.1046/j.1365-2036.2002.01335.x. PMID: 12197847.
- Moreira TR, Leonhardt D, Conde SR. INFLUENCE OF DRINKING A PROBIOTIC FERMENTED MILK BEVERAGE CONTAINING BIFIDOBACTERIUM ANIMALIS ON THE SYMPTOMS OF CONSTIPATION. Arq Gastroenterol. 2017 Jul-Sept;54(3):206-210. doi: 10.1590/S0004-2803.201700000-27. Epub 2017 May 25. PMID: 28591244.
- Laake KO, Bjørneklett A, Aamodt G, Aabakken L, Jacobsen M, Bakka A, Vatn MH. Outcome of four weeks’ intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis. Scand J Gastroenterol. 2005 Jan;40(1):43-51. doi: 10.1080/00365520410009339. PMID: 15841713.
- Tonucci LB, Olbrich Dos Santos KM, Licursi de Oliveira L, Rocha Ribeiro SM, Duarte Martino HS. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clin Nutr. 2017 Feb;36(1):85-92. doi: 10.1016/j.clnu.2015.11.011. Epub 2015 Dec 7. PMID: 26732026.
- Tejada-Simon MV, Lee JH, Ustunol Z, Pestka JJ. Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice. J Dairy Sci. 1999 Apr;82(4):649-60. doi: 10.3168/jds.S0022-0302(99)75281-1. PMID: 10212452.